| Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression Q Hu, Y Ye, LC Chan, Y Li, K Liang, A Lin, SD Egranov, Y Zhang, W Xia, ... Nature immunology 20 (7), 835-851, 2019 | 277 | 2019 |
| Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails Y Fu, C Huang, X Xu, H Gu, Y Ye, C Jiang, Z Qiu, X Xie Cell research 25 (9), 1013-1024, 2015 | 258 | 2015 |
| Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer J Qi, H Sun, Y Zhang, Z Wang, Z Xun, Z Li, X Ding, R Bao, L Hong, W Jia, ... Nature communications 13 (1), 1742, 2022 | 248 | 2022 |
| YTHDF3 induces the translation of m6A-enriched gene transcripts to promote breast cancer brain metastasis G Chang, L Shi, Y Ye, H Shi, L Zeng, S Tiwary, JT Huse, L Huo, L Ma, ... Cancer cell 38 (6), 857-871. e7, 2020 | 242 | 2020 |
| The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy Y Ye, Y Xiang, FM Ozguc, Y Kim, CJ Liu, PK Park, Q Hu, L Diao, Y Lou, ... Cell systems 6 (3), 314-328. e2, 2018 | 200 | 2018 |
| A pan-cancer analysis of the expression and clinical relevance of small nucleolar RNAs in human cancer J Gong, Y Li, C Liu, YU Xiang, C Li, Y Ye, Z Zhang, DH Hawke, PK Park, ... Cell reports 21 (7), 1968-1981, 2017 | 195 | 2017 |
| PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types J Gong, S Mei, C Liu, Y Xiang, Y Ye, Z Zhang, J Feng, R Liu, L Diao, ... Nucleic acids research 46 (D1), D971-D976, 2018 | 189 | 2018 |
| Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer Z Zhang, JH Lee, H Ruan, Y Ye, J Krakowiak, Q Hu, Y Xiang, J Gong, ... Nature communications 10 (1), 4562, 2019 | 188 | 2019 |
| EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma R Fang, X Chen, S Zhang, H Shi, Y Ye, H Shi, Z Zou, P Li, Q Guo, L Ma, ... Nature communications 12 (1), 177, 2021 | 185 | 2021 |
| Sex-associated molecular differences for cancer immunotherapy Y Ye, Y Jing, L Li, GB Mills, L Diao, H Liu, L Han Nature communications 11 (1), 1779, 2020 | 171 | 2020 |
| Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy Y Ye, Q Hu, H Chen, K Liang, Y Yuan, Y Xiang, H Ruan, Z Zhang, A Song, ... Nature metabolism 1 (4), 431-444, 2019 | 154 | 2019 |
| Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer H Chen, J Yao, R Bao, Y Dong, T Zhang, Y Du, G Wang, D Ni, Z Xun, ... Molecular cancer 20, 1-21, 2021 | 145 | 2021 |
| Nobiletin fortifies mitochondrial respiration in skeletal muscle to promote healthy aging against metabolic challenge K Nohara, V Mallampalli, T Nemkov, M Wirianto, J Yang, Y Ye, Y Sun, ... Nature communications 10 (1), 3923, 2019 | 143 | 2019 |
| Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy Y Jing, J Liu, Y Ye, L Pan, H Deng, Y Wang, Y Yang, L Diao, SH Lin, ... Nature communications 11 (1), 4946, 2020 | 137 | 2020 |
| ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 axis H Liu, X Kuang, Y Zhang, Y Ye, J Li, L Liang, Z Xie, L Weng, J Guo, H Li, ... Cancer cell 37 (3), 324-339. e8, 2020 | 137 | 2020 |
| Comprehensive characterization of alternative polyadenylation in human cancer Y Xiang, Y Ye, Y Lou, Y Yang, C Cai, Z Zhang, T Mills, NY Chen, Y Kim, ... JNCI: Journal of the National Cancer Institute 110 (4), 379-389, 2018 | 130 | 2018 |
| Comprehensive characterization of circular RNAs in~ 1000 human cancer cell lines H Ruan, Y Xiang, J Ko, S Li, Y Jing, X Zhu, Y Ye, Z Zhang, T Mills, J Feng, ... Genome medicine 11, 1-14, 2019 | 126 | 2019 |
| Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy Y Liu, Z Xun, K Ma, S Liang, X Li, S Zhou, L Sun, Y Liu, Y Du, X Guo, T Cui, ... Journal of hepatology 78 (4), 770-782, 2023 | 113 | 2023 |
| ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation Y Yang, M Wu, D Cao, C Yang, J Jin, L Wu, X Hong, W Li, L Lu, J Li, ... Science Advances 7 (41), eabf6290, 2021 | 100 | 2021 |
| Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1 Y Ye, X Kuang, Z Xie, L Liang, Z Zhang, Y Zhang, F Ma, Q Gao, R Chang, ... Genome medicine 12, 1-19, 2020 | 97 | 2020 |
Leng HanDavid Brown Chair Professor in Genomic Medicine, Indiana University School of MedicineAdresse e-mail validée de iu.edu
